Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medstar Diabetes Institute; | UNKNOWN |
| American Diabetes Association | OTHER |
| Bayer | INDUSTRY |
| CareFirst BlueCross Blue Shield; |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A concise diabetes self-management education (DSME) program on the "ABCs of Diabetes" will be placed in an urban public library to assess the feasibility of using this community setting for the delivery of health care education in an urban African American population. Impact on knowledge of, prescriptions for, and control of blood sugar (A1C), blood pressure (BP) and LDL cholesterol (LDL-C)before and after participation in the program will be assessed. We will also examine the frequency of emergency department (ED) visits and hospitalizations for uncontrolled diabetes at 6 months post-DSME intervention.
A free, community-based Diabetes Learning Center was placed in a public library. Adults with diabetes (N=360) consented to participate in this prospective cohort study with historic self-controls. The small group, interactive DSME (two 2-1/2 hour classes) focused on improving CVD risk factors and enabling communication with the primary care physician. Knowledge, prescriptions, diabetes-related testing and clinical outcomes were assessed.
"ABCs of Diabetes" DSME Program
Class #1: A1C, Aspirin & Blood Pressure
A. Curriculum Content Areas:
B. Education strategies & tools
Class #2 Cholesterol and Meal Planning
A. Curriculum Content Areas:
consistent carbohydrate
B. Education strategies & tools
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diabetes Self-Management Education | Other | Education intervention with historic self-controls. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Diabetes Self-Management Education | Behavioral | DSME intervention consisting of two interactive 2-1/2 hour classes taught by a diabetes educator focusing on the "ABCs of diabetes" and training in how to talk to your doctor. |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement in the percent of subjects correctly identifying guideline-recommended treatment targets for the "ABC's of Diabetes", where A = A1C < 7%; B = BP <130/80mmHg and; and C = LDL-C < 100mg/dl. | 6 months following program completion |
| Measure | Description | Time Frame |
|---|---|---|
| increase the percentage of subjects taking medications for A1C, BP and LDL-C management and aspirin; | 6 months following DSME program completion | |
| increase scores on the diabetes self-efficacy scale (DES); | 6 months following DSME program completion |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michelle F. Magee, MD, LRCPSI | Medstar Health Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | United States |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Feb 9, 2022 | |
| Reset | Apr 13, 2022 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Feb 9, 2022 | Apr 13, 2022 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| UNKNOWN |
| District of Columbia, Department of Health Block Grants Program; | UNKNOWN |
| Charles and Mary Latham Trust Fund; | UNKNOWN |
| Eli Lilly and Company | INDUSTRY |
| Hewlett-Packard | INDUSTRY |
| Meltzer Entities; | UNKNOWN |
| NBC Washington | OTHER |
| Novo Nordisk A/S | INDUSTRY |
| Aventis Pharmaceuticals | INDUSTRY |
| Takeda Pharmaceuticals North America, Inc. | INDUSTRY |
| Pfizer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
| increase percentage of patients with A1C, BP and LDL-C at recommended targets; | 6 months following program completion |
| Decrease the percentage of participants with self-reported ED visits and hospitalizations for severe hypoglycemia and hyperglycemia. | 6 months following DSME program completion |